This paper appraises convolutional neural network (CNN) models’ capabilities in emotion detection from facial expressions, seeking to aid the diagnosis of psychosomatic illnesses, typically made in clinical setups. Using the FER-2013 dataset, two CNN models were designed to detect six emotions with 64% accuracy—although not evenly distributed; they demonstrated higher effectiveness in identifying “happy” and “surprise.” The assessment was performed through several performance metrics—accuracy, precision, recall, and F1-scores—besides further validation with an additional simulated clinical environment for practicality checks. Despite showing promising levels for future use, this investigation highlights the need for extensive validation studies in clinical settings. This research underscores AI’s potential value as an adjunct to traditional diagnostic approaches while focusing on wider scope (broader datasets) plus focus (multimodal integration) areas to be considered among recommendations in forthcoming studies. This study underscores the importance of CNN models in developing psychosomatic diagnostics and promoting future development based on ethics and patient care.

This study introduces an AI-based framework for stroke diagnosis that merges clinical data and curated imaging data. The system utilizes traditional machine learning and advanced deep learning techniques to tackle dataset imbalances and variability in stroke presentations. Our approach involves rigorous data preprocessing, feature engineering, and ensemble techniques to optimize the predictive performance. Comprehensive evaluations demonstrate that gradient-boosted models outperform in accuracy, while CNNs enhance stroke detection rates. Calibration and threshold optimization are utilized to align predictions with clinical requirements, ensuring diagnostic reliability. This multi-modal framework highlights the capacity of AI to accelerate stroke diagnosis and aid clinical decision making, ultimately enhancing patient outcomes in critical care.

The paper emphasizes the critical importance of the initial phase in IT project development to avoid implementation errors. It argues that minimizing these errors can be achieved by developing project artifacts at the early stage using a model-driven engineering-based approach. Model transformation plays a basic role in that context. The goal of this paper is to survey publications in which the authors propose generating initial project elements through model-driven engineering and to analyze the level of model transformations offered in their solutions. As a result, the authors would highlight the necessity of understanding which elements of a project can be obtained through automatic transformations and which still require manual manipulation. This distinction is crucial, as it can significantly influence the efficiency and accuracy of the project’s early phases. In general, identifying the project components that can be reliably generated through model transformations helps streamline the project inception and elaboration process performed before IT product implementation.

We present a neuro-fuzzy digital twin for cardiac disease recognition on the PTB-XL dataset that keeps the accuracy of a strong convolutional model while exposing its reasoning as readable fuzzy rules. The key design choice is to separate the two jobs instead of forcing one network to do both. A convolutional backbone (xresnet1d101 with cross-lead attention) is trained first and acts as the predictor. A second phase then freezes the backbone and trains a five-expert mixture of interval Type-2 Adaptive Neuro-Fuzzy Inference Systems as an interpretation layer, attached through a learnable trust gate. Four experts read complementary signal streams (the raw 12-lead waveform, a Fourier–Bessel Series Expansion, a Tunable-Q Wavelet Transform, and a morphogram); a fifth reads 22 clinical and demographic descriptors. A concept bottleneck maps the backbone embedding to eight named clinical concepts (ST elevation, T inversion, QT prolongation, Sokolov–Lyon and Cornell voltages, RVH, axis deviation, QRS widening), so the downstream rules read in clinical language. Two genetic-algorithm stages keep the model compact: NSGA-II selects the clinical features, and a multi-objective rule-pruning search trades macro-F1 and hypertrophy recall against the number of active rules. On the official test fold the twin reaches a macro-F1 of 0.751 (bootstrap 95% CI 0.740 to 0.767), a macro-AUC of 0.928, a Matthews correlation coefficient of 0.672, and a macro expected calibration error of 0.021, which is above the Strodthoff xresnet1d101 baseline of 0.74 and well below the calibration error of our earlier coupled design. Because the fuzzy layer is attached as a trust-gated residual and the best epoch is chosen on threshold-optimized validation F1, the interpretable twin matches the backbone within about 0.004 (twin 0.751 versus backbone 0.754) rather than paying the usual “interpretability tax”. The fuzzy mixture on its own still reaches a macro-F1 of 0.69, so the rules carry real diagnostic signal. Subgroup macro-F1 stays within about 0.045 across sex, age, and body-mass groups. A concept-level intervention simulator estimates how cardioactive drug classes would shift a patient’s risk by perturbing the named concepts and re-running the same twin.